Company news
Enzolytics Inc. news in 2024
Enzolytics Inc.'s news releases, calls and decks from 2024, newest first.
Enzolytics, Inc. announces implementation of capital restructuring plan as part of ongoing acquisition strategy offers update on sagaliam acquisition corp
November 5, 2024
Enzolytics, Inc. Addresses Additional Misinformation
October 23, 2024
Enzolytics Inc. Response to Competitor’s Continuing False and Misleading Statements Regarding Zhabilov Trust Patents Statements were Included in NIKA Pharmaceuticals June 30, 2024 10-Q filed with SEC
October 13, 2024
Enzolytics, Inc. and department of immunology, institute of microbiology, bulgarian academy of sciences begins project focusing on development of Melanoma vaccine
October 6, 2024
Bulgarian Academy of Sciences Issues Report on Results of Its In Vivo Testing of IPF as an Immunomodulator
September 17, 2024
Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement
September 8, 2024
Final Report From the National Centre of Infectious and Parasitic Diseases Concludes Lyophilized Pepsin Significantly Reduces the Survival and Proliferation of Growth in Specific Cancer Cells
August 19, 2024
Enzolytics, Inc. and the Bulgarian Academy of Sciences Initiate a Cooperative Program Primarily Focusing on Applied and Strategic Research in Immunology for Cancer and HIV/AIDS Applications
July 30, 2024
Enzolytics, Inc. Enters Into Collaboration Agreement With Manufacturer Elimus Ltd.
July 28, 2024
Enzolytics Inc. Supports Sagaliam Acquisition Corp Response to Competitors False and Misleading Press Release
July 25, 2024
Sagalium responds to competitor’s false and misleading press release
July 24, 2024
Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment
June 30, 2024
Enzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room Temperature SPAD Technology
June 2, 2024
Enzolytics, Inc. Announces Letter of Intent for Exclusive Licensing Agreement for Patented Nitric Oxide Formulation
May 21, 2024
Enzolytics, Inc. announces letter of intent for exclusive licensing agreement for patented nitric oxide formulation
May 21, 2024
Enzolytics, Inc. Announces Formation of Marketing Company in Partnership with Third Coast Fulfillment
May 1, 2024
Enzolytics, Inc. shareholders hold special meeting and elect new board
March 24, 2024
Enzolytics, Inc. Announces Partnership With the Khalpey AI Lab To Forge the Future of Multi-Organ Remodeling and Rejuvenation With a Strategic Focus on Longevity
January 15, 2024